Impact 49: SGLT2 inhibitors in CKD: are they really effective in all patients?
490
9 ماه پیش
SGLT2 inhibitors in CKD: are they really effective in all patients?...
SGLT2 inhibitors in CKD: are they really effective...
04:16
490
9 ماه پیش
04:16
Impact 48: DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR
498
9 ماه پیش
DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR...
DOACs for Rheumatic Heart Disease-Associated AF Po...
03:41
498
9 ماه پیش
03:41
Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis
461
9 ماه پیش
Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis...
Case Discussion 124: Anticoagulation in Patients w...
05:27
461
9 ماه پیش
05:27
23rd ACC 2025 Congress Coverage: FAME 3 Trial
441
9 ماه پیش
23rd ACC 2025 Congress Coverage: FAME 3 Trial...
23rd ACC 2025 Congress Coverage: FAME 3 Trial
01:26
441
9 ماه پیش
01:26
22nd ACC 2025 Congress Coverage: FLAVOUR II Trial
492
9 ماه پیش
22nd ACC 2025 Congress Coverage: FLAVOUR II Trial...
22nd ACC 2025 Congress Coverage: FLAVOUR II Trial
03:04
492
9 ماه پیش
03:04
21st ACC 2025 Congress Coverage: DapaTavi Trial
464
9 ماه پیش
🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors Progressing to New Standard After TAVI, DapaTAVI Trial, by Dr. Tahamtan, Fellowship of Electrophysiology.🔸Stay tuned for more insights from the late-...
🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors ...
01:54
464
9 ماه پیش
01:54
20th ACC 2025 Congress Coverage: ALLEPRE Trial
430
9 ماه پیش
🫀20th ACC.25 Congress Coverage: Alliance for secondary prevention after an acute coronary syndrome, ALLEPRE Trial, by Dr. Nasrollahizadeh, General Practitioner.🔸Stay tuned for more insights from the...
🫀20th ACC.25 Congress Coverage: Alliance for seco...
02:13
430
9 ماه پیش
02:13
19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease
452
9 ماه پیش
19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease...
19th ACC 2025 Congress Coverage: HPV Infection and...